Tscan Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases through the intersection of immunotherapy and genomics

The company utilizes its proprietary technology platform to identify and harness T cell receptors that can specifically target tumor antigens, enabling the creation of personalized T cell therapies. By leveraging its expertise in T cell biology and advanced genomics, Tscan aims to improve patient outcomes and deliver more effective treatment options for various forms of cancer, with the goal of transforming the landscape of cancer therapy.